Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

2812, 2024

Qian Meng et al., Excessive erythrophagocytosis accounts for systemic inflammation in chronic kidney disease

2303, 2024

Giulia Paesello et al., Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World

2203, 2024

Albino Eccher et al., Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing

1903, 2024

Marco Capezzone et al., Identification of a Novel Non-V600E BRAF Mutation in Papillary Thyroid Cancer

1603, 2024

Melchior Linea et al., Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC

2702, 2024

Federica Di Maggio et al., A Novel DNA Variant in SMARCA4 Gene Found in a Patient Affected by Early Onset Colon Cancer

2002, 2024

Fabio Canino et al., Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients

2002, 2024

Zahra Abrehdari-Tafreshi et al., The Role of miR-29a and miR-143 on the Anti-apoptotic MCL-1/cIAP-2 Genes Expression in EGFR Mutated Non-small Cell Lung Carcinoma Patients

1402, 2024

Lorenza Rimassa et al., Phase II Study of Tivantinib and Cetuximab in Patients With KRAS Wild-type Metastatic Colorectal Cancer With Acquired Resistance to EGFR Inhibitors and Emergence of MET Overexpression: Lesson Learned for Future Trials With EGFR/MET Dual Inhibition

1102, 2024

Angela Santoro et al., Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs

202, 2024

Samantha Epistolio et al., Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis

2701, 2024

Combination of Maria Cristina Sini et al., Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population

12 Successivo

Pubblicazioni

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Pubblicazioni

Leader in Italia nella ricerca e nella commercializzazione di kit diagnostici per test farmacogenetici

Cerca pubblicazione

Filtra per anno

Cerca per primo autore

Leader in Italia nella ricerca e nella
commercializzazione di kit diagnostici
per test farmacogenetici